# STPG1

## Overview
STPG1, or sperm tail PG-rich repeat containing 1, is a gene that encodes a protein of the same name, which is characterized by its proline and glycine-rich repeat regions. This protein is primarily associated with the regulation of cellular processes related to cancer biology, particularly in the context of gastric cancer. The STPG1 protein is involved in modulating immune responses and cellular signaling pathways, such as the ERK signaling pathway, which plays a critical role in cell proliferation and survival. Alterations in the expression of STPG1 have been linked to changes in cancer cell viability and immune system interactions, highlighting its potential as a target for therapeutic interventions in cancer treatment (Chen2022ThPOK).

## Structure


## Clinical Significance
STPG1 (sperm tail PG-rich repeat containing 1) has been implicated in various clinical conditions due to alterations in its expression levels and interactions. In the context of gastric cancer, STPG1 expression is notably lower in cancerous tissues compared to normal tissues. This reduced expression is associated with increased cancer cell viability and immune escape mechanisms. Overexpression of STPG1 has been shown to suppress gastric cancer cell viability and promote T cell activation, suggesting its potential role in enhancing immune responses against cancer cells (Chen2022ThPOK).

STPG1 is also involved in the inactivation of the ERK signaling pathway, which is crucial for cell proliferation and survival. Both STPG1 and the transcription factor ThPOK, which regulates STPG1 expression, contribute to the inactivation of this pathway, thereby reducing cancer cell viability and promoting immune activation (Chen2022ThPOK). These findings highlight the potential clinical significance of STPG1 in modulating immune responses and signaling pathways in gastric cancer, suggesting that alterations in STPG1 expression could influence cancer progression and patient prognosis (Chen2022ThPOK).


## References


[1. (Chen2022ThPOK) Ying Chen, Lili Jiang, Lingli Xia, Gang Zhang, and Lan Chen. Thpok inhibits the immune escape of gastric cancer cells by inducing stpg1 to inactivate the erk pathway. BMC Immunology, April 2022. URL: http://dx.doi.org/10.1186/s12865-022-00485-5, doi:10.1186/s12865-022-00485-5. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12865-022-00485-5)